Insider Transactions in Q4 2025 at Janux Therapeutics, Inc. (JANX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2025
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,333
-3.77%
|
$99,990
$30.0 P/Share
|
|
Nov 14
2025
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+3.64%
|
$33,330
$10.59 P/Share
|
|
Oct 28
2025
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
16,665
-16.87%
|
$499,950
$30.06 P/Share
|
|
Oct 28
2025
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,665
+8.06%
|
$116,655
$7.4 P/Share
|